new-era_cover

New-Era_Cover

Designing Human-Centric Clinical Trials

The rate of technological progress shows no sign of slowing down. What was once measured in years is now measured in months. And yet, clinical trials really haven’t changed all that much in the past decade. This is surprising because there has never been a more urgent need to improve the development of new treatments. But the status quo ends today.
For pharmaceutical companies, the priority is to increase the speed of trial and therefore the time to market, reduce cost, increase patient retention and improve the likelihood of discovering new end points. All this must be achieved without impacting patient safety or treatment efficacy. Clinical trials that take a human-centric approach to their design are more likely to deliver on these goals.
Human-centric clinical trials, utilizing decentralized and hybrid models, are reshaping medical research. By improving our understanding of both patient and healthcare professional behaviors–the lifeblood of any clinical trial–we can identify common problems and ensure we design trials that alleviate common issues and in turn improve engagement, efficiency and the overall experience for those taking part.
In this point of view, we examine how emerging technology creates opportunities to accelerate meaningful change in clinical research. We look at the impact of human-centric design that utilizes technology (e.g., telemedicine and wearable devices, remote participation solutions). This includes accelerated and more efficient drug development and the elimination of geographic, logistical and socio-economic barriers that often exclude some underrepresented groups from trial participation.
Our aim is to highlight ways to improve patient engagement, foster higher retention rates, gather richer data and promote more representative outcomes. This expert insight highlights how decentralized and hybrid clinical trials are paving the way to equitable, global healthcare solutions, ensuring life-saving treatments are accessible to all.

Designing Human-Centric Clinical Trials 
Connecting Research with People 

new-era_report_mockup

New-Era_Report_mockup

How human-centricity improves upon traditional clinical trials

Human-centricity leverages remote monitoring and virtual consultations to include patients from rural or remote areas who would otherwise be excluded due to the proximity required in traditional trials.

Eliminating geographic barriers

Inclusivity is embedded in human-centric design. By considering factors such as digital literacy, language preferences and accessibility, trials can be tailored to support participants from varying backgrounds.

Catering to diverse needs

Patients are at the heart of the human-centric model. Flexible schedules, at-home data collection and real-time remote support reduce the burden of participation. Minimized disruption to daily life promotes higher retention rates.

Enhancing patient-centricity

Wearable devices, electronic patient-reported outcomes (ePRO) and real-world evidence (RWE) integration enable seamless data collection. These tools also allow for continuous monitoring, ensuring the inclusion of participants with mobility or transportation constraints.

Leveraging technology for representation

Bringing everyone into the fold

<h2>From assessment to action</h2>
<h3>frog’s approach to clinical trials</h3>
At frog, we take a human-centric approach to designing clinical trials. We engage both site teams and patients to foster optimal conditions. This endows us with an understanding of the unique challenges and behavioral pressures that prevent patients from joining and adhering throughout the course of the trial.
Our methodology is designed to help clients unleash the full potential of their clinical trials, making them more efficient and effective.
frog can help you with:
<ol>
<li>Design and planning</li>
<li>Patient experience and monitoring</li>
<li>Technology and remote data collection</li>
<li>Automation of processes</li>
</ol>
We believe clinical trials must be accessible to people from all walks of life. A flexible, hybrid approach is the key to success.

Jenny Berkeley

Articles

	Global		EN
	France		FR
	China		CN

	Global		EN
	France		FR
	China		CN